USE OF CANNABIS FOR MEDICINAL PURPOSES
The Council on Science and Public Health recommends that the following statement be adopted in lieu of Resolutions 910 (I-08), 921 (I-08), and 229 (A-09) and the remainder of the report be filed.
Our American Medical Association (AMA) urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines. This should not be viewed as an endorsement of state-based medical cannabis programs, the legalization of marijuana, or that scientific evidence on the therapeutic use of cannabis meets the current standards for a prescription drug product. (New HOD Policy)
So it it might have come as a surprise on Tuesday when the AMA announced that, after 72 years, it was reversing its pot policy—and urged the federal government to do the same. Precipitated by a similar decision by the group’s Medical Student Section, the AMA resolved that “that marijuana’s status as a federal Schedule 1 controlled substance be reviewed,” with the goal of facilitating clinical research, and presented a new medical report, conducted by the AMA Council on Science and Public Health, laying out the drug’s various medical benefits.